Investigating the effect of dehydromiltirone on septic AKI using a network pharmacology method, molecular docking, and experimental validation

被引:0
|
作者
Chen, Sijia [1 ]
Wang, Yanzhe [1 ]
Liu, Yuyuan [2 ]
Bai, Linnan [3 ]
Li, Fengqin [1 ]
Wu, Yue [1 ]
Xie, Xinmiao [1 ]
Zhang, Nan [1 ]
Zeng, Chuchu [1 ]
Zhang, Ling [4 ]
Wang, Xiaoxia [1 ]
机构
[1] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Nephrol, Sch Med, Shanghai, Peoples R China
[2] Nanjing Med Univ, Suzhou Hosp, Suzhou Municipal Hosp, Dept Nephrol, Suzhou, Jiangsu, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Nephrol, Sch Med, Hangzhou, Peoples R China
[4] Univ Elect Sci & Technol China, Chengdu Womens & Childrens Cent Hosp, Sch Med, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
septic AKI; network pharmacology; dehydromiltirone; COX2; apoptosis; mitochondrial dysfunction; inflammatory; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; SEVERE SEPSIS; MITOCHONDRIA; DYSFUNCTION;
D O I
10.3389/fphar.2023.1145675
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acute kidney injury (AKI) is a severe and frequent complication of sepsis that occurs in intensive care units with inflammation and rapid decline in renal function as the main pathological features. Systemic inflammation, microvascular dysfunction, and tubule injury are the main causes of sepsis-induced AKI (SI-AKI). The high prevalence and death rate from SI-AKI is a great challenge for clinical treatment worldwide. However, in addition to hemodialysis, there is no effective drug to improve renal tissue damage and alleviate the decline in kidney function. We conducted a network pharmacological analysis of Salvia miltiorrhiza (SM), a traditional Chinese medicine, which is widely used for the treatment of kidney disease. Then, we combined molecular docking and a dynamics simulation to screen for the active monomer dehydromiltirone (DHT) that has therapeutic effects on SI-AKI and investigated its potential mechanism of action through experimental validation. The components and targets of SM were obtained by searching the database, and 32 overlapping genes were screened by intersection analysis with AKI targets. GO and KEGG data showed that the functions of a common gene were closely related to oxidative stress, mitochondrial function, and apoptosis. The molecular docking results combined with molecular dynamics simulations provide evidence for a binding model between DHT and cyclooxygenase-2 (COX2), both of which are mainly driven by van der Waals interactions and a hydrophobic effect. In vivo, we found that mice pretreated with an intraperitoneal injection of DHT (20 mg/kg/d) for 3 days ameliorated CLP surgery-induced renal function loss and renal tissue damage and inhibited inflammatory mediators IL-6, IL-1 beta, TNF-a, and MCP-1 production. In vitro, the DHT pretreatment decreased LPS-induced expression of COX2, inhibited cell death and oxidative stress, alleviated mitochondrial dysfunction, and restrained apoptosis in HK-2 cells. Our research indicates that the renal preventive effect of DHT is related to maintaining mitochondrial dynamic balance, restoring mitochondrial oxidative phosphorylation, and inhibiting cell apoptosis. The findings in this study provide a theoretical basis and a novel method for the clinical therapy of SI-AKI.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Hypoglycemic Effect and Experimental Validation of Scutellariae Radix based on Network Pharmacology and Molecular Docking
    Liu, Xiaolong
    Li, Chunyan
    Chen, Qijian
    Xiao, Xian
    Li, Manman
    Xue, Jintao
    PROCESSES, 2022, 10 (12)
  • [2] Investigating the molecular mechanism of epimedium herb in treating rheumatoid arthritis through network pharmacology, molecular docking, and experimental validation
    Ding, Chunhui
    Liu, Qingyang
    You, Xiaohong
    Yuan, Jianming
    Xia, Jinjun
    Tan, Yuan
    Hu, Yunxia
    Wang, Qiubo
    MOLECULAR DIVERSITY, 2025,
  • [3] Effect of Apples on Hemolysis-Induced Hyperbilirubinemia: Evaluation by Network Pharmacology and Molecular Docking and Experimental Validation
    An Q.
    Wei Y.
    Li Q.
    Wang J.
    Yue G.
    Wang Z.
    Shipin Kexue/Food Science, 2024, 45 (09): : 144 - 152
  • [4] The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
    Wang, Yanzhe
    Liu, Yuyuan
    Chen, Sijia
    Li, Fengqin
    Wu, Yue
    Xie, Xinmiao
    Zhang, Nan
    Zeng, Chuchu
    Bai, Linnan
    Dai, Mengshi
    Zhang, Ling
    Wang, Xiaoxia
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [5] Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation
    Gong, Zhaohui
    Yang, Haixin
    Gao, Li
    Liu, Yi
    Chu, Qingmin
    Luo, Chuanjin
    Kang, Liang
    Zhai, Huiqi
    Xu, Qiang
    Wu, Wei
    Li, Nan
    Li, Rong
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2025, 25 (01)
  • [6] Investigating the molecular mechanism of iguratimod act on SLE using network pharmacology and molecular docking analysis
    Zeng, Huiqiong
    Chen, Shuai
    Lu, Xiaoping
    Yan, Zhenbo
    FRONTIERS IN BIOINFORMATICS, 2022, 2
  • [7] Investigating the Molecular Mechanisms of Resveratrol in Treating Cardiometabolic Multimorbidity: A Network Pharmacology and Bioinformatics Approach with Molecular Docking Validation
    Gong, Wei
    Sun, Peng
    Li, Xiujing
    Wang, Xi
    Zhang, Xinyu
    Cui, Huimin
    Yang, Jianjun
    NUTRIENTS, 2024, 16 (15)
  • [8] Effect and Mechanism of Schizandrin A in the Treatment of Liver Cancer Using Network Pharmacology, Molecular Docking, and Target Validation
    Wang, Xiaohui
    Zhou, Lin
    Zhang, Tao
    Chen, Hui
    Song, Xinhao
    Wang, Feng
    NATURAL PRODUCT COMMUNICATIONS, 2023, 18 (05)
  • [9] Exploring the protective effect and molecular mechanism of betulin in Alzheimer's disease based on network pharmacology, molecular docking and experimental validation
    Wang, Na
    Cui, Jiali
    Sun, Ziteng
    Chen, Fan
    He, Xiaping
    MOLECULAR MEDICINE REPORTS, 2024, 30 (06)
  • [10] Investigation of the mechanism of baicalein in the treatment of periodontitis based on network pharmacology, molecular docking and experimental validation
    Liu, Yue
    Cao, Fengdi
    Shi, Mingyue
    Deng, Zhuohang
    Guo, Kaili
    Fan, Tiantian
    Meng, Yuhan
    Bu, Mingyang
    Ma, Zhe
    BMC ORAL HEALTH, 2024, 24 (01):